Tirzepatide
Dual GIP / GLP-1 agonist$50per research vial · USD
Tirzepatide is a dual GIP and GLP-1 receptor agonist widely referenced in preclinical metabolic and incretin-signaling research.
Available strengths
1
Certificate of Analysis
Search code: BGSR2607010598
Report date: 07/03/2026
Purity: 99.74%
View COAFor Research Use Only. Not for human or veterinary use. This product is intended strictly for in-vitro laboratory research and development and is sold to qualified researchers only.
